DRY AGE-RELATED MACULAR DEGENERATION
Clinical trials for DRY AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new DRY AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for DRY AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial for dry AMD shows early promise but study halted
Disease control TerminatedThis study tested a single injection of a gene therapy called GT005 in 56 people with dry age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to see if it was safe and could slow or stop damage to the retina. The trial was stopped early, so result…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 08:18 UTC
-
Gene therapy shot for dry AMD shows promise but study halted early
Disease control TerminatedThis study tested a single injection of a gene therapy called GT005 in 98 people with geographic atrophy, a severe form of dry age-related macular degeneration that causes vision loss. The goal was to see if the treatment could slow the growth of damaged areas in the eye. The stu…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 08:13 UTC
-
Gene therapy for dry AMD shows promise but trial halted early
Disease control TerminatedThis study tested a single injection of a gene therapy called GT005 into the eye to treat geographic atrophy, a severe form of dry age-related macular degeneration that causes vision loss. The trial included 255 adults aged 55 and older and measured changes in the size of the dam…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 08:12 UTC